TG Therapeutics, Inc

3 Columbus Cir Fl 15
New York, NY 10019

TG Therapeutics, Inc. is a biopharmaceutical company based in New York, NY, focused on developing innovative therapies for various diseases, including multiple sclerosis (MS). Their approved product, BRIUMVI, is indicated for the treatment of relapsing forms of MS in adults, offering a new option for patients with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

With a strong emphasis on research and development, TG Therapeutics, Inc. has a robust pipeline of products, including Umbralisib, Ublituximab, TG-1701, and TG-1801. The company's dedication to advancing medical science and improving patient outcomes is evident in their commitment to addressing unmet medical needs and achieving significant milestones in the field of healthcare.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew YorkNew YorkTG Therapeutics, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.